Page last updated: 2024-11-03
risperidone and Anaplastic Oligodendroglioma
risperidone has been researched along with Anaplastic Oligodendroglioma in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Stupinski, J | 1 |
Kim, J | 1 |
Francois, D | 1 |
Other Studies
1 other study available for risperidone and Anaplastic Oligodendroglioma
Article | Year |
---|---|
Delusional Disorder Arising From a CNS Neoplasm.
Topics: Antipsychotic Agents; Brain Neoplasms; Delusions; Female; Frontal Lobe; Humans; Magnetic Resonance I | 2017 |